Insider Transactions in Q3 2021 at Nu Skin Enterprises, Inc. (NUS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
16,000
-47.14%
|
$752,000
$47.41 P/Share
|
|
Sep 13
2021
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+32.04%
|
$480,000
$30.63 P/Share
|
|
Sep 08
2021
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.08%
|
$539
$49.54 P/Share
|
|
Sep 01
2021
|
Ryan S Napierski President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,707
+12.54%
|
-
|
|
Aug 01
2021
|
Chayce David Clark EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,863
+10.44%
|
-
|
|
Jul 02
2021
|
D Matthew Dorny General Counsel |
SELL
Open market or private sale
|
Direct |
6,200
-5.83%
|
$353,400
$57.08 P/Share
|
|
Jul 02
2021
|
D Matthew Dorny General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+10.41%
|
$186,000
$30.63 P/Share
|